Report      Database

    Global Non Invasive Prenatal Testing Market, Test Volume & Forecast

    Date: 27 Oct, 2014              Type: Life Science              Pages: 67

    Global Non Invasive Prenatal Testing Market, Test Volume & Forecast
    • Electronic Access - Single User License
      $1,400.00
    • CD-ROM Mail Delivery
      $1,500.00
    • Hard-copy Mail Delivery
      $1,550.00
    • Electronic Access - Multi User License
      $2,200.00

    The development of the non–invasive prenatal test (NIPT) has transformed the prenatal testing market. NIPT has the potential to drastically change how pregnancies are managed. Non–invasive prenatal genetic testing (NIPT) has been commercially available since 2011 and has been rapidly adopted in the US and in parts of Europe. Recently, companies have also started marketing NIPT in low– and middle–income countries (LMICs).

    Sequenom, Inc. was the first company that offered its proprietary non–invasive prenatal test MaterniT21 PLUS for detecting fetal chromosomal aneuploidies in pregnant women in October 2011, and since then it is leading the market. Sequenom, Inc. accounts for XXX% of the total revenue generated in the global NIPT market, followed by Verifi test with a market share of XXX% in the year 2013. Non invasive prenatal testing market will touch XX Billion marks by the year 2019 and it is expected to show substantial growth of more than 150% from 2014 to 2019. 
     
    Prenatal diagnosis gives parents and medical professionals a chance to manage high–risk pregnancies and provides advanced warning of any possible birth complications, which increases the chances of having a healthy baby. The increase in the maternal age along with rising fetal abnormalities and advancement in the realm of non–invasive prenatal testing method will drive the market for NIPT.

    Renub Research study titled “Global Non–Invasive Prenatal Testing Market, Test Volume & Forecast” explores a comprehensive assessment of the fast–evolving, high growth Global Non–Invasive Prenatal Testing Market. This 67 page report with 32 Figures and 12 Tables provides estimates of the test volume, as well as market and market shares for leading non–invasive prenatal testing, comparative analysis of the non–invasive prenatal testing and different deals type in non–invasive prenatal testing market.

    All the 8 NIPT tests studied in the report are as follows

    1. MaterniT21 PLUS Test
    2. Harmony Prenatal Test
    3. Verifi Prenatal Test
    4. Panorama Prenatal Test
    5. NIFTY Test
    6. Bambni Test
    7. Prena Test
    8. NIPD Test

    Data Sources
     
    This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts. 

    Primary sources include industry surveys and telephone interviews with industry experts. 
     
    Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases. 

    1. Executive Summary

    2. Global Non–Invasive Prenatal Testing Market, Volume & Forecast (2011 – 2019) 
    2.1 Global Non–Invasive Prenatal Testing Market & Forecast
    2.2 Global Non–Invasive Prenatal Testing Volume & Forecast

    3. Global Non–Invasive Prenatal Testing Market & Volume Share (2011 – 2019) 
    3.1 Global Non–Invasive Prenatal Testing Market Share & Forecast
    3.2 Global Non–Invasive Prenatal Testing Volume Share & Forecast

    4. Global Non–Invasive Prenatal Testing Market & Volume, by Test, (2012 – 2019) 
     
    4.1 Sequenom Laboratories MaterniT21 PLUS Test Market & Volume
    4.1.1 Sequenom Laboratories MaterniT21 PLUS Test Volume & Forecast
    4.1.2 Sequenom Laboratories MaterniT21 PLUS Test Market & Forecast

    4.2 Ariosa Diagnostics Harmony Prenatal Test Market & Volume
    4.2.1 Ariosa Diagnostics Harmony Prenatal Test Volume & Forecast
    4.2.2 Ariosa Diagnostics Harmony Prenatal Test Market & Forecast

    4.3 Illumina Inc (Verinata Health) Verifi Prenatal Test Market & Volume
    4.3.1 Illumina Inc (Verinata Health) Verifi Prenatal Test Volume & Forecast
    4.3.2 Illumina Inc (Verinata Health) Verifi Prenatal Test Market & Forecast

    4.4 Natera Panorama Prenatal Test Market & Volume
    4.4.1 Natera Panorama Prenatal Test Volume & Forecast
    4.4.2 Natera Panorama Prenatal Test Market & Forecast

    4.5 BGI Health NIFTY Test Market & Volume
    4.5.1 BGI Health NIFTY Test Volume & Forecast
    4.5.2 BGI Health NIFTY Test Market & Forecast

    4.6 Berry Genomics Bambni Test Market & Volume
    4.6.1 Berry Genomics Bambni Test Volume & Forecast
    4.6.2 Berry Genomics Bambni Test Market & Forecast

    4.7 Life Codexx Prena Test Market & Volume
    4.7.1 Life Codexx Prena Test Volume & Forecast
    4.7.2 Life Codexx Prena Test Market & Forecast

    4.8 NIPD Genetics NIPD Test Market & Volume
    4.8.1 NIPD Genetics NIPD Test Volume & Forecast
    4.8.2 NIPD Genetics NIPD Test Market & Forecast

    5. Non–Invasive Prenatal Testing – Comparative Tests Analysis

    6. Deals Type in Non–Invasive Prenatal Testing Market
     
    6.1 Collaboration Deals in Non–Invasive Prenatal Testing
    6.1.1 Year 2007
    6.1.2 Year 2013

    6.2 Partnership Deals in Non–Invasive Prenatal Testing
    6.2.1 Year 2012
    6.2.2 Year 2013
    6.2.3 Year 2014

    6.3 Distribution Agreement Deals in Non–Invasive Prenatal Testing
    6.3.1 Year 2012
    6.3.2 Year 2013

    6.4 Licensing Agreement Deals in Non–Invasive Prenatal Testing
    6.4.1 Year 2007
    6.4.2 Year 2011
    6.4.3 Year 2013

    6.5 Exclusive Agreement Deals in Non–Invasive Prenatal Testing
    6.5.1 Year 2008
    6.5.2 Year 2013

    6.6 Merger & Acquisition Deals in Non–Invasive Prenatal Testing
    6.6.1 Year 2013

    6.7 Venture Capital Investment Deals in Non–Invasive Prenatal Testing
    6.7.1 Year 2011
    6.7.2 Year 2012
    6.7.3 Year 2013

    7. Growth Drivers in Non Invasive Prenatal Testing Market
    7.1 High Incidence Rate of Babies Born with Down Syndrome

    8. Challenges in Non Invasive Prenatal Testing Market
    8.1 Regulatory Guidelines and Ethical Hurdles 

    List of Figures:

    Figure 2–1: Global – Non–Invasive Prenatal Testing Market (Million US$), 2011 – 2013
    Figure 2–2: Global – Forecast for Non–Invasive Prenatal Testing Market (Million US$), 2014 – 2019
    Figure 2–3: Global – Non–Invasive Prenatal Testing Volume (Number), 2011 – 2013
    Figure 2–4: Global – Forecast for Non–Invasive Prenatal Testing Volume (Number), 2014 – 2019

    Figure 4–1: Global – Sequenom Laboratories MaterniT21 PLUS Test Volume (Number), 2011 – 2013
    Figure 4–2: Global – Forecast for Sequenom Laboratories MaterniT21 PLUS Test Volume (Number), 2014 – 2019
    Figure 4–3: Global – Sequenom Laboratories MaterniT21 PLUS Test Market (Million US$), 2011 – 2013
    Figure 4–4: Global – Forecast for Sequenom Laboratories MaterniT21 PLUS Test Market (Million US$), 2014 – 2019
    Figure 4–5: Global – Ariosa Diagnostics Harmony Prenatal Test Volume (Number), 2012–2013
    Figure 4–6: Global – Forecast for Ariosa Diagnostics Harmony Prenatal Test Volume (Number), 2014–2019
    Figure 4–7: Global – Ariosa Diagnostics Harmony Prenatal Test Market (Million US$), 2012–2013
    Figure 4–8: Global – Forecast for Ariosa Diagnostics Harmony Prenatal Test Market (Million US$), 2014–2019
    Figure 4–9: Global – Verinata Health Verifi Prenatal Test Volume (Number), 2012 – 2013
    Figure 4–10: Global – Forecast for Verinata Health Verifi Prenatal Test Volume (Number), 2014 – 2019
    Figure 4–11: Global – Verinata Health Verifi Prenatal Test Market (Million US$), 2012 – 2013
    Figure 4–12: Global – Forecast for Verinata Health Verifi Prenatal Test Market (Million US$), 2014 – 2019
    Figure 4–13: Global – Natera Panorama Prenatal Test Volume & Forecast (Number), 2013 – 2019
    Figure 4–14: Global – Natera Panorama Prenatal Test Market & Forecast (Million US$), 2013 – 2019
    Figure 4–15: Global – BGI Health NIFTY Test Volume (Number), 2012 – 2013
    Figure 4–16: Global – Forecast for BGI Health NIFTY Test Volume (Number), 2014 – 2019
    Figure 4–17: Global – BGI Health NIFTY Test Market (Million US$), 2012 – 2013
    Figure 4–18: Global – Forecast for BGI Health NIFTY Test Market (Million US$), 2014 – 2019
    Figure 4–19: Global – Berry Genomics Bambni Test Volume (Number), 2012 – 2013
    Figure 4–20: Global – Forecast for Berry Genomics Bambni Test Volume (Number), 2014 – 2019
    Figure 4–21: Global – Berry Genomics Bambni Test Market (Million US$), 2012 – 2013
    Figure 4–22: Global – Forecast for Berry Genomics Bambni Test Market (Million US$), 2014 – 2019
    Figure 4–23: Global – Life Codexx Prena Test Volume (Number), 2012 – 2013
    Figure 4–24: Global – Forecast for Life Codexx Prena Test Volume (Number), 2014 – 2019
    Figure 4–25: Global – Life Codexx Prena Test Market (Million US$), 2012 – 2013
    Figure 4–26: Global – Forecast for Life Codexx Prena Test Market (Million US$), 2014 – 2019
    Figure 4–27: Global – NIPD Genetics NIPD Test Volume & Forecast (Number), 2013 – 2019
    Figure 4–28: Global – NIPD Genetics NIPD Test Market & Forecast (Million US$), 2013 – 2019

    List of Tables:

    Table 3 1: Global – Non–Invasive Prenatal Testing Market Share (Percent), 2012 – 2013
    Table 3 2: Global – Forecast for Non–Invasive Prenatal Testing Market Share (Percent), 2014 – 2019
    Table 3 3: Global – Non–Invasive Prenatal Testing Volume Share (Percent), 2012 – 2013
    Table 3 4: Global – Forecast for Non–Invasive Prenatal Testing Volume Share (Percent), 2014 – 2019

    Table 5 1: Non–Invasive Prenatal Testing – Comparative Tests Analysis

    Table 6 1: Collaboration Deals in Non–Invasive Prenatal Testing, 2007 – 2013
    Table 6 2: Partnership Deals in Non–Invasive Prenatal Testing, 2012 – 2014
    Table 6 3: Distribution Agreement Deals in Non–Invasive Prenatal Testing, 2012 – 2013
    Table 6 4: Licensing Agreement Deals in Non–Invasive Prenatal Testing, 2007 – 2013
    Table 6 5: Exclusive Agreement Deals in Non–Invasive Prenatal Testing, 2008 – 2013
    Table 6 6: Merger & Acquisition Deals in Non–Invasive Prenatal Testing, 2013
    Table 6 7: Venture Capital Investment Deals in Non–Invasive Prenatal Testing, 2011 – 2013 

    • Description
      Price
    • Chapter 1 & 2     Pages : 5
      $200
    • Chapter 3     Pages : 4
      $350
    • Chapter 4     Pages : 30
      $375
    • Chapter 5     Pages : 2
      $100
    • Chater 6     Pages : 11
      $350
    • Chapter 7     Pages : 1
      $50
    • Chapter 8     Pages : 1
      $50

    Related Products

    • United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020


      United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020
      Liquid Biopsy Tests are emerging as a viable alternative to traditional methods for cancer screening. A liquid biopsy is a new type of blood test that has the potential to transform cancer treatment. Using this methodology, physicians avoid the traditional surgical and needle biopsies they use to de...
      Date: 12 Jan, 2016
      Type: Diagnostics
      Pages: 79
      Price: $900.00
    • Food Safety Testing (By Contaminant, Pathogen, Technology & Region) - Global Forecast


      Food Safety Testing (By Contaminant, Pathogen, Technology & Region) - Global Forecast
      The usage of food safety testing has made huge impact over the past years in view of growing incidences of food-borne illnesses and poisoning caused by contaminated food products. The global market for food safety testing is growing in healthy CAGR of more than 6% between 2015 and 2020. ...
      Date: 23 Dec, 2015
      Type: Diagnostics
      Pages: 100
      Price: $1,290.00